Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C127 - Neuro-oncology: Navigating Current Trends

Tuesday 04/16/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | 207
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Wendy Sherman, MD
Neuro-oncology
Participants should increase their knowledge regarding key clinical trial evidence supporting advancements in the treatment of primary and secondary central nervous system tumors, and integrate emerging evidence into treatment paradigms for patients with primary and secondary central nervous system tumors.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:40 PM MDT Speaker Updates in Management of IDH Mutated Astrocytoma
Ugur Sener, MD
01:40 PM - 02:20 PM MDT Speaker Updates in Management of Glioblastoma
Lauren Rhea Schaff, MD
02:20 PM - 03:00 PM MDT Speaker Update in the Management of Metastatic Disease for the CNS
Wendy Sherman, MD
Faculty Disclosures
Wendy Sherman, MD Dr. Sherman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Focused ultrasound foundation . Dr. Sherman has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Kiyatec.
Ugur Sener, MD Dr. Sener has nothing to disclose.
Lauren Rhea Schaff, MD Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO. Dr. Schaff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. An immediate family member of Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MichieHamlett Attorneys at Law. The institution of Dr. Schaff has received research support from BTG, plc. The institution of Dr. Schaff has received research support from Merck. The institution of Dr. Schaff has received research support from DebioPharm.